Turning wild-type phages into drug-grade ε²Phages® 

What makes PhagoMed’s ε²Phages® special?​

PhagoMed creates novel phage genotypes through directed inter-crossings of wild-type phages on our ε² Directed Evolution platform. The resulting ε²Phages® are highly evolved and optimized for therapeutic applications:

​

• Optimized for high host range & low resistance formation

• Only natural inter-crossing techniques used to create ε²Phages® 

• Bio-availability optimized for the exact treatment setting

• Broad patent protection secured